iShares Listed Private Equity UCITS ETF USD (Dist) USD is a equity ETF from iShares tracking the Listed Private Equity index through physical replication. Domiciled in Ireland and launched in 2007, the fund manages about 683 M € and charges a TER of 0.75% — 75 € per year on a €10,000 investment. Income is paid out to investors periodically (distributing).
iShares Listed Private Equity UCITS ETF USD (Dist) USD competes with 1 other products on the same index (Listed Private Equity): it ranks 1st by fund size and 1st by ongoing cost, with a TER of 0.75% against a group median of 0.75%. It has been listed since 2007, 19 years of track record.
On a €10,000 investment the TER costs 75 € a year, and no product in the group costs less.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 51.6% of the portfolio.
Income is distributed periodically: it produces cash flow, but reinvesting it is up to you if the goal is capital growth. The fund is denominated in USD. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
Irish domicile lets the fund apply the Ireland–US tax treaty, with 15% withholding instead of 30% on US dividends received by the fund.
| Brookfield Corporation | 7.7% |
| Blackstone Group Inc | 7.4% |
| 3I Group PLC | 6.1% |
| KKR & Co. Inc. | 5.3% |
| Washington H Soul Pattinson & Company Ltd | 4.8% |
| Apollo Global Management LLC Class A | 4.6% |
| Ares Capital Corporation | 4.0% |
| Brookfield Asset Management Ltd | 4.0% |
| Partners Group Holding AG | 3.9% |
| EQT AB (publ) | 3.8% |
| XETRA | IQQL | EUR |
| Francoforte | IQQL | EUR |
| London Stock Exchange | IPRV | GBX |
| London Stock Exchange | IDPE | USD |
| Euronext Amsterdam | IPRV | EUR |
| SIX Swiss Exchange | IPRV | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.